SCHEMBL19928451

SCHEMBL19928451

CC(C)c1cc(S)no1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL85820 0.72 GRM5 (0.44)
SCHEMBL468941 0.72
SCHEMBL22215300 0.71 SMN1; SMN2 (0.36)
SCHEMBL18000492 0.70
SCHEMBL20843934 0.70
SCHEMBL14425145 0.70
SCHEMBL1012703 0.70
SCHEMBL20375530 0.70
SCHEMBL21341850 0.69
SCHEMBL25979186 0.68 SMN1; SMN2 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024130341-A1 BENZIMIDAZOLE DERIVATIVES FOR THE MODULATION OF STING Aculeus Therapeutics Pty Ltd (AU) 2024-06-27 WO disclosed
US-20210040092-A1 INHIBITORS OF INFLUENZA VIRUSES REPLICATION VERTEX PHARMACEUTICALS INCORPORATED 2021-02-11 US disclosed
WO-2020153433-A1 SUBSTITUENT-INCLUDING UREA COMPOUND 第一三共株式会社 2020-07-30 WO disclosed
US-9908878-B2 Inhibitors of influenza viruses replication VERTEX PHARMACEUTICALS INCORPORATED (US) 2018-03-06 US disclosed